Literature DB >> 17218271

Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARgamma.

Serena Ghisletti1, Wendy Huang, Sumito Ogawa, Gabriel Pascual, Mu-En Lin, Timothy M Willson, Michael G Rosenfeld, Christopher K Glass.   

Abstract

Transrepression is widely utilized to negatively regulate gene expression, but the mechanisms by which different nuclear receptors effect gene- and signal-specific transrepression programs remain poorly understood. Here, we report the identification of alternative SUMOylation-dependent mechanisms that enable PPARgamma and LXRs to negatively regulate overlapping but distinct subsets of proinflammatory genes. Ligand-dependent conjugation of SUMO2/3 to LXRs or SUMO1 to PPARgamma targets them to promoters of TLR target genes, where they prevent the signal-dependent removal of NCoR corepressor complexes required for transcriptional activation. SUMO1-PPARgamma and SUMO2/3-LXRs inhibit distinct NCoR clearance mechanisms, allowing promoter- and TLR-specific patterns of repression. Mutational analysis and studies of naturally occurring oxysterol ligands indicate that the transactivation and SUMOylation-dependent transrepression activities of LXRs can be independently regulated. These studies define parallel but functionally distinct pathways that are utilized by PPARgamma and LXRs to differentially regulate complex programs of gene expression that control immunity and homeostasis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17218271      PMCID: PMC1850387          DOI: 10.1016/j.molcel.2006.11.022

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  49 in total

1.  The PROactive study: some answers, many questions.

Authors:  Hannele Yki-Järvinen
Journal:  Lancet       Date:  2005-10-08       Impact factor: 79.321

2.  NXP-2 association with SUMO-2 depends on lysines required for transcriptional repression.

Authors:  Adam Rosendorff; Shuhei Sakakibara; Sixin Lu; Elliott Kieff; Yan Xuan; Alessandra DiBacco; Yujiang Shi; Yang Shi; Grace Gill
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

Review 3.  Liver X receptors as integrators of metabolic and inflammatory signaling.

Authors:  Noam Zelcer; Peter Tontonoz
Journal:  J Clin Invest       Date:  2006-03       Impact factor: 14.808

Review 4.  Combinatorial roles of nuclear receptors in inflammation and immunity.

Authors:  Christopher K Glass; Sumito Ogawa
Journal:  Nat Rev Immunol       Date:  2006-01       Impact factor: 53.106

5.  Domain exchange between human toll-like receptors 1 and 6 reveals a region required for lipopeptide discrimination.

Authors:  Katherine O Omueti; John M Beyer; Christopher M Johnson; Elizabeth A Lyle; Richard I Tapping
Journal:  J Biol Chem       Date:  2005-08-29       Impact factor: 5.157

6.  Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus.

Authors:  Steven M Haffner; Andrew S Greenberg; Wayde M Weston; Hongzi Chen; Ken Williams; Martin I Freed
Journal:  Circulation       Date:  2002-08-06       Impact factor: 29.690

7.  Promoter-specific roles for liver X receptor/corepressor complexes in the regulation of ABCA1 and SREBP1 gene expression.

Authors:  Brandee L Wagner; Annabel F Valledor; Gang Shao; Chris L Daige; Eric D Bischoff; Mary Petrowski; Kristen Jepsen; Sung Hee Baek; Richard A Heyman; Michael G Rosenfeld; Ira G Schulman; Christopher K Glass
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

8.  PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages.

Authors:  John S Welch; Mercedes Ricote; Taro E Akiyama; Frank J Gonzalez; Christopher K Glass
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-09       Impact factor: 11.205

9.  Transcriptional activity of peroxisome proliferator-activated receptor gamma is modulated by SUMO-1 modification.

Authors:  Takayuki Ohshima; Hiroshi Koga; Kunitada Shimotohno
Journal:  J Biol Chem       Date:  2004-04-28       Impact factor: 5.157

10.  Macrophage/cancer cell interactions mediate hormone resistance by a nuclear receptor derepression pathway.

Authors:  Ping Zhu; Sung Hee Baek; Eliot M Bourk; Kenneth A Ohgi; Ivan Garcia-Bassets; Hideki Sanjo; Shizuo Akira; Paul F Kotol; Christopher K Glass; Michael G Rosenfeld; David W Rose
Journal:  Cell       Date:  2006-02-10       Impact factor: 41.582

View more
  242 in total

1.  A mouse macrophage lipidome.

Authors:  Edward A Dennis; Raymond A Deems; Richard Harkewicz; Oswald Quehenberger; H Alex Brown; Stephen B Milne; David S Myers; Christopher K Glass; Gary Hardiman; Donna Reichart; Alfred H Merrill; M Cameron Sullards; Elaine Wang; Robert C Murphy; Christian R H Raetz; Teresa A Garrett; Ziqiang Guan; Andrea C Ryan; David W Russell; Jeffrey G McDonald; Bonne M Thompson; Walter A Shaw; Manish Sud; Yihua Zhao; Shakti Gupta; Mano R Maurya; Eoin Fahy; Shankar Subramaniam
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

Review 2.  Crosstalk between reverse cholesterol transport and innate immunity.

Authors:  Kathleen M Azzam; Michael B Fessler
Journal:  Trends Endocrinol Metab       Date:  2012-03-10       Impact factor: 12.015

Review 3.  General molecular biology and architecture of nuclear receptors.

Authors:  Michal Pawlak; Philippe Lefebvre; Bart Staels
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

Review 4.  Liver X receptors, atherosclerosis and inflammation.

Authors:  Daryn R Michael; Tim G Ashlin; Melanie L Buckley; Dipak P Ramji
Journal:  Curr Atheroscler Rep       Date:  2012-06       Impact factor: 5.113

5.  PPARs and lipid ligands in inflammation and metabolism.

Authors:  Gregory S Harmon; Michael T Lam; Christopher K Glass
Journal:  Chem Rev       Date:  2011-10-12       Impact factor: 60.622

6.  Rosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III study.

Authors:  Michael Gold; Claire Alderton; Marina Zvartau-Hind; Sally Egginton; Ann M Saunders; Michael Irizarry; Suzanne Craft; Gary Landreth; Ulla Linnamägi; Sharon Sawchak
Journal:  Dement Geriatr Cogn Disord       Date:  2010-08-21       Impact factor: 2.959

Review 7.  Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells.

Authors:  Christopher K Glass; Kaoru Saijo
Journal:  Nat Rev Immunol       Date:  2010-05       Impact factor: 53.106

8.  FoxO1 regulates Tlr4 inflammatory pathway signalling in macrophages.

Authors:  Wuqiang Fan; Hidetaka Morinaga; Jane J Kim; Eunju Bae; Nathanael J Spann; Sven Heinz; Christopher K Glass; Jerrold M Olefsky
Journal:  EMBO J       Date:  2010-11-02       Impact factor: 11.598

Review 9.  Toxicological and pathophysiological roles of reactive oxygen and nitrogen species.

Authors:  Ruth A Roberts; Robert A Smith; Stephen Safe; Csaba Szabo; Ronald B Tjalkens; Fredika M Robertson
Journal:  Toxicology       Date:  2010-07-17       Impact factor: 4.221

Review 10.  The Intracellular Cholesterol Landscape: Dynamic Integrator of the Immune Response.

Authors:  Michael B Fessler
Journal:  Trends Immunol       Date:  2016-09-28       Impact factor: 16.687

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.